Last checked at 16 Feb 2021 06:50
Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative
Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades4,024
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,642.50
Bid:
1,642.50
Ask:
1,643.00
Change:
3.00 (0.18%)
Spread:
0.50 (0.03%)
Open:
1,650.50
High:
1,656.00
Low:
1,637.00
Prev. Close:
1,639.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.15 Feb 2021 16:00
15.3 million Britons receive first coronavirus vaccine dose
LONDON, Feb 15 (Reuters) - A total of 15,300,151 Britons have received the first dose of a COVID-19 jab, according to official data released on Monday, as the government begins to widen its vaccination programme to new groups of people.Britain als...
Read more15 Feb 2021 12:17
Sanofi Covid-19 vaccines may be ready by end of 2021
(Sharecast News) - French drug giant Sanofi's two vaccine candidates against Covid-19 may be ready by year-end, the company said, refuting an earlier report.
Read more12 Feb 2021 16:01
More than 14 million Britons have received first COVID-19 vaccine dose
LONDON, Feb 12 (Reuters) - A total of 14,012,224 Britons have received the first dose of a COVID-19 vaccine, official data showed on Friday, as the government races to vaccinate the most vulnerable people.Britain on Friday also reported 758 deaths...
Read more12 Feb 2021 09:33
BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy
BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy
Read more11 Feb 2021 16:09
11 Feb 2021 15:54
UPDATE 1-Novartis buys antibiotics business from GSK in generics push
(Writes through with details from GSK)ZURICH, Feb 11 (Reuters) - Swiss drugmaker Novartis' generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and Fortum for up to $500 million, the drugmaker...
Read more11 Feb 2021 14:24
Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy
Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy
Read more11 Feb 2021 14:18
Thursday broker round-up
(Sharecast News) - JD Wetherspoons: Peel Hunt downgrades to reduce with a target price of 1,150p.
Read more11 Feb 2021 12:14
Novartis buys GSK's cephalosporin business for $350 mln
ZURICH, Feb 11 (Reuters) - Novartis's Sandoz generics division is buying GlaxoSmithKline's cephalosporin antibiotics business that includes three brands sold in more than 100 markets, it said on Thursday.Sandoz will pay GSK $350 million at closing...
Read more11 Feb 2021 09:36
BROKER RATINGS: Investec Cuts NatWest To Sell; UBS Raises Aggreko
BROKER RATINGS: Investec Cuts NatWest To Sell; UBS Raises Aggreko
Read more9 Feb 2021 09:31
BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut
BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut
Read more8 Feb 2021 14:17
TOP NEWS: GlaxoSmithKline Notes EU Approval For HIV Drug Rukobia
TOP NEWS: GlaxoSmithKline Notes EU Approval For HIV Drug Rukobia
Read more8 Feb 2021 09:35
BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell
BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell
Read more7 Feb 2021 10:46
UPDATE 2-UK says COVID-19 booster and annual vaccinations very probable
* Minister expects annual vaccinations may be needed* Govt not planning vaccine passports -Nadhim Zahawi* UK reports a further 15,845 cases, 373 deaths (Adds latest figures, line on vaccine passports)By Costas PitasLONDON, Feb 7 (Reuters) - A COVID-...
Read more